Clin2
NCT07781293Possibly a fitNot yet recruiting

Adding lurasidone to antidepressants for major depression

Major Depressive Disorder (MDD)Major Depressive Disorder With Psychotic Features

Part of Mental health clinical trials.

This study tests whether adding an antipsychotic medicine called lurasidone to your current antidepressant can help reduce depression symptoms. Participants must have tried an antidepressant without enough improvement and continue taking their current antidepressant during the trial.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
364 people
Ages
19 years to 64 years
Study type
Interventional

Who can take part

  • You are between 19 and 65 years old.
  • You have been diagnosed with major depressive disorder (MDD).
  • Your current depressive episode has lasted at least 8 weeks.
  • You have tried an antidepressant (like sertraline, escitalopram, duloxetine, bupropion, or others) for at least 6 weeks without enough improvement.
  • You must be willing to keep taking your current antidepressant during the study.
  • You cannot have certain other mental health conditions or recent substance abuse.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06830044Recruiting· Phase 3
Adding an experimental drug for major depression

This trial tests if adding a new medicine called milsaperidone can help people with major depression who haven't gotten enough relief from their current antidepressant. It aims to see if the combination works better than the antidepressant alone.

Phoenix, Arizona
NCT07226661Recruiting· Phase 2
Study of an investigational drug for depression

This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.

Garden Grove, California
NCT06958692Recruiting· Phase 3
Testing a new antidepressant combination for depression

This study tests a new combination of two medications (dextromethorphan and bupropion) as a treatment for major depressive disorder. It may be an option if you have not already tried many antidepressants that didn't work.

Beijing, Beijing Municipality
NCT06827431Not yet recruiting· Phase 3
Testing ammoxetine for depression

This trial tests an investigational medication called ammoxetine for people with moderate to severe depression. It aims to see if the drug can reduce depressive symptoms and is for those who haven't had success with certain other antidepressants.

NCT05850689Recruiting· Phase 3
Lumateperone add-on for major depression that didn’t improve

This study tests whether adding lumateperone to an antidepressant helps adults with major depressive disorder (MDD) who haven’t improved enough after trying at least two different antidepressants. It may help reduce depressive symptoms more than antidepressants alone.

Huntsville, Alabama
NCT07747389Not yet recruiting· Phase 3
Lumateperone for major depressive disorder

This study tests whether the drug lumateperone can help people with moderate to severe depression. If you join, you may receive the study drug or a placebo (a pill with no active medicine) to see if it improves your symptoms.

Hear when a new Major Depressive Disorder (MDD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.